Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DBS Systems
Gland, Vaud, Switzerland
- Ownership
- Private
- Development stage
- Other
01
Overview
DBS System's HemaXis platform, including HemaXis DB and HemaXis DX, is commercialized for minimally invasive, micro-sample blood and plasma collection using patented microfluidic devices. The devices are CE-marked and FDA listed (Class 1), sold in the EU and US, and used for certified lab and wellness diagnostics workflows[9][11][12].
- Therapeutic areas
- OtherPsychiatry
- Modalities
- DeviceMicrofluidic device
- Industry
- Consumable Medical Devices
02
Partnerships
Certified laboratories in Europe and the US
Beyond the preview
Go deeper on DBS Systems.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DBS Systems.